Skip to main navigation Skip to search Skip to main content

Anticancer activities of bis(pyrazol-1-ylthiocarbonyl)disulfides against HeLa cells

  • Frankline K. Keter
  • , Margo J. Nell
  • , Ilia A. Guzeic
  • , Bernard Omondia
  • , James Darkwaa
  • University of Johannesburg
  • University of Pretoria
  • University of Wisconsin-Madison

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Oxidation of the pyrazol-1-yldithiocarbamate compounds {[3, 5-R 2C3HN2CS2]- (R = H, Me} and indazol-1- lydithiocarbamate by iodine produces the sulfur-sulfur coupling compounds {R'C(S)S-S(S)CR'} (R' = pyrazolyl, 3, 5-dimethylpyrazolyl, indazolyl). All compounds were spectroscopically characterised, and, in some cases, structurally characterised. The X-ray structures reveal that these compounds contain a disulfide bridging the pyrazolylthiocarbonyl units. Two of the three disulfide compounds showed very good anticancer activities against HeLa cells at micromolar concentrations, with the most active compound active being 9.6 times more selective in its activity towards tumour cells than normal cells.

Original languageEnglish
Pages (from-to)322-325
Number of pages4
JournalJournal of Chemical Research - Part S
Issue number5
DOIs
Publication statusPublished - May 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anticancer
  • Disulfide
  • Dithiocarbamates
  • HeLa cells
  • Indazolyl
  • Pyrazolyl

ASJC Scopus subject areas

  • General Chemistry

Fingerprint

Dive into the research topics of 'Anticancer activities of bis(pyrazol-1-ylthiocarbonyl)disulfides against HeLa cells'. Together they form a unique fingerprint.

Cite this